Zobrazeno 1 - 5
of 5
pro vyhledávání: '"direct antiviral action drugs"'
Autor:
N. V. Dunaeva, E. Yu. Kolpashchikova, S. Yu. Romanova, S. N. Kizhlo, S. V. Lapin, D. A. Gusev
Publikováno v:
Журнал инфектологии, Vol 10, Iss 4, Pp 53-63 (2018)
The aim of the study was to evaluate clinical, immunologic and anti-viral efficacy of antiviral therapy (АVT) with drugs of the direct antiviral action (DAA) of the chronic hepatitis C (CHC) complicated with secondary mixed cryoglobulinemia in small
Externí odkaz:
https://doaj.org/article/a5cd7da3adef44e384fcdff6a7f4b9fe
Publikováno v:
Медицинский совет, Vol 0, Iss 14, Pp 75-79 (2016)
Objective of review: to present new approaches to therapy of patients with chronic NCV-infection based on the clinical use of the direct antiviral action drug Sofosbuvir.Major provisions: until recently a standard approach to therapy of HCV-infection
Externí odkaz:
https://doaj.org/article/8c891b643c2a40ce819776d7fc52dac8
Autor:
S.V. Lapin, E. Yu. Kolpashchikova, S. Yu. Romanova, D. A. Gusev, Svetlana Kizhlo, N.V. Dunaeva
Publikováno v:
Žurnal Infektologii, Vol 10, Iss 4, Pp 53-63 (2018)
The aim of the study was to evaluate clinical, immunologic and anti-viral efficacy of antiviral therapy (АVT) withdrugs of the direct antiviral action (DAA) of the chronic hepatitis C (CHC) complicated with secondary mixed cryoglobulinemia in small
Autor:
Santana,Alice, Rodrigues,Natacha
Publikováno v:
Portuguese Journal of Nephrology & Hypertension, Volume: 29, Issue: 4, Pages: 292-30514, Published: DEC 2015
Portuguese Journal of Nephrology & Hypertension v.29 n.4 2015
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Portuguese Journal of Nephrology & Hypertension v.29 n.4 2015
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
The prevalence of hepatitis C virus infection is several times higher in the sub-population of patients with chronic end -stage renal disease on dialysis, or transplanted. Therapy with Interferon and Ribavirin was for many years the gold standard tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b48015f449abab0cf67b81e70717d052
http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-01692015000400005&lng=en&tlng=en
http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-01692015000400005&lng=en&tlng=en
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.